1. Home
  2. MD vs AVBP Comparison

MD vs AVBP Comparison

Compare MD & AVBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MD
  • AVBP
  • Stock Information
  • Founded
  • MD 1979
  • AVBP 2021
  • Country
  • MD United States
  • AVBP United States
  • Employees
  • MD N/A
  • AVBP N/A
  • Industry
  • MD Hospital/Nursing Management
  • AVBP
  • Sector
  • MD Health Care
  • AVBP
  • Exchange
  • MD Nasdaq
  • AVBP NYSE
  • Market Cap
  • MD 1.0B
  • AVBP 948.5M
  • IPO Year
  • MD 1995
  • AVBP 2024
  • Fundamental
  • Price
  • MD $16.04
  • AVBP $35.28
  • Analyst Decision
  • MD Hold
  • AVBP Strong Buy
  • Analyst Count
  • MD 6
  • AVBP 5
  • Target Price
  • MD $14.92
  • AVBP $36.80
  • AVG Volume (30 Days)
  • MD 768.4K
  • AVBP 129.8K
  • Earning Date
  • MD 11-01-2024
  • AVBP 11-15-2024
  • Dividend Yield
  • MD N/A
  • AVBP N/A
  • EPS Growth
  • MD N/A
  • AVBP N/A
  • EPS
  • MD N/A
  • AVBP N/A
  • Revenue
  • MD $2,006,998,000.00
  • AVBP N/A
  • Revenue This Year
  • MD $2.42
  • AVBP N/A
  • Revenue Next Year
  • MD N/A
  • AVBP N/A
  • P/E Ratio
  • MD N/A
  • AVBP N/A
  • Revenue Growth
  • MD N/A
  • AVBP N/A
  • 52 Week Low
  • MD $6.62
  • AVBP $14.35
  • 52 Week High
  • MD $16.41
  • AVBP $36.20
  • Technical
  • Relative Strength Index (RSI)
  • MD 81.21
  • AVBP 75.00
  • Support Level
  • MD $12.29
  • AVBP $28.50
  • Resistance Level
  • MD $16.41
  • AVBP $32.01
  • Average True Range (ATR)
  • MD 0.55
  • AVBP 1.56
  • MACD
  • MD 0.32
  • AVBP 0.35
  • Stochastic Oscillator
  • MD 93.69
  • AVBP 99.48

About MD Pediatrix Medical Group Inc.

Pediatrix Medical Group Inc provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment and generates majority of the revenue through neonatology and other pediatric subspecialties.

About AVBP ARRIVENT BIOPHARMA INC

ArriVent BioPharma Inc is a clinical stage biopharmaceutical company dedicated to the identification, development and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers. It seeks to utilize team's deep drug development experience to maximize the potential of lead development candidate, furmonertinib, and advance a pipeline of novel therapeutics, such as next-generation antibody drug conjugates, through approval and commercialization in patients suffering from cancer, with an initial focus on solid tumors.

Share on Social Networks: